Total Payments
$717,102
2024 Payments
$145,011
Companies
43
Transactions
666
Medicare Patients
10,781
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$351,921 (49.1%)
Consulting$298,503 (41.6%)
Travel$34,025 (4.7%)
Food & Beverage$13,362 (1.9%)
Research$11,825 (1.6%)
Education$7,403 (1.0%)
Gifts$61.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $298,503 | 146 | 41.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $129,153 | 49 | 18.0% |
| Honoraria | $66,213 | 12 | 9.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $61,125 | 14 | 8.5% |
| Grant | $51,024 | 5 | 7.1% |
| Travel and Lodging | $34,025 | 103 | 4.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $32,000 | 14 | 4.5% |
| Food and Beverage | $13,362 | 308 | 1.9% |
| Charitable Contribution | $12,407 | 1 | 1.7% |
| Unspecified | $11,825 | 5 | 1.6% |
| Education | $7,403 | 8 | 1.0% |
| Gift | $61.89 | 1 | 0.0% |
Payments by Type
General
$705,277
661 transactions
Research
$11,825
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $123,344 | 85 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $92,242 | 88 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $84,494 | 63 | $0 (2021) |
| ABBVIE INC. | $77,420 | 73 | $0 (2024) |
| Sight Sciences, Inc. | $62,232 | 26 | $0 (2024) |
| Alcon Vision LLC | $50,577 | 61 | $0 (2024) |
| Glaukos Corporation | $43,824 | 22 | $0 (2024) |
| Alcon Laboratories Inc | $30,423 | 50 | $0 (2018) |
| EllexiScience | $22,968 | 5 | $0 (2019) |
| NeoMedix Corporation | $16,640 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145,011 | 151 | Bausch & Lomb Americas Inc. ($51,632) |
| 2023 | $116,797 | 91 | Sight Sciences, Inc. ($33,778) |
| 2022 | $50,722 | 63 | Katena Products, Inc. ($12,563) |
| 2021 | $71,936 | 37 | Bausch & Lomb, a division of Bausch Health US, LLC ($29,275) |
| 2020 | $94,157 | 48 | Bausch & Lomb, a division of Bausch Health US, LLC ($36,871) |
| 2019 | $93,754 | 108 | Aerie Pharmaceuticals, Inc. ($27,632) |
| 2018 | $96,531 | 117 | Bausch & Lomb, a division of Bausch Health US, LLC ($40,370) |
| 2017 | $48,193 | 51 | NEOMEDIX CORPORATION ($15,140) |
All Payment Transactions
666 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Ophthalmology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Glaukos Corporation | iDose (Device) | Travel and Lodging | Cash or cash equivalent | $468.00 | General |
| Category: Glaucoma | ||||||
| 12/09/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $186.16 | General |
| Category: Glaucoma | ||||||
| 12/05/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: EYE CARE | ||||||
| 11/27/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Glaucoma | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $46.62 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
| Category: Glaucoma | ||||||
| 11/20/2024 | Glaukos Corporation | iDose (Device) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Glaucoma | ||||||
| 11/20/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/14/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: EYE CARE | ||||||
| 11/13/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: EYE CARE | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: EYE CARE | ||||||
| 10/29/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $232.13 | General |
| Category: Glaucoma | ||||||
| 10/28/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $589.62 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Retrospective Assessment of Latanoprostene Bunod Ophthalmic Solution 0.024 in Patients Newly Diagnosed with Open Angle Glaucoma or Ocular Hypertension | Bausch Health US, LLC | $9,325 | 4 |
| Retrospective Chart Review of the Use of Vyzulta in Switch Patients | Bausch & Lomb Americas Inc. | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,555 | 3,437 | $2.3M | $364,579 |
| 2022 | 21 | 2,480 | 3,364 | $1.9M | $331,179 |
| 2021 | 24 | 2,918 | 3,745 | $2.5M | $385,320 |
| 2020 | 24 | 2,828 | 3,455 | $971,694 | $370,056 |
Total Patients
10,781
Total Services
14,001
Medicare Billing
$1.5M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 138 | 229 | $507,006 | $71,767 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 356 | 487 | $213,793 | $46,224 | 21.6% |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2023 | 19 | 280 | $224,840 | $45,254 | 20.1% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 39 | 60 | $190,860 | $38,727 | 20.3% |
| 66174 | Dilation of fluid outflow drainage within eye | Facility | 2023 | 42 | 65 | $249,275 | $31,102 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 309 | 453 | $137,259 | $23,031 | 16.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 343 | 371 | $94,866 | $16,330 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 139 | 139 | $92,157 | $15,370 | 16.7% |
| 0449T | Insertion of initial aqueous fluid drainage device into eye | Facility | 2023 | 24 | 26 | $206,674 | $15,061 | 7.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 377 | 408 | $61,517 | $10,372 | 16.9% |
| 65855 | Laser repair to improve eye fluid flow | Facility | 2023 | 43 | 61 | $61,561 | $9,747 | 15.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 32 | 36 | $48,456 | $8,899 | 18.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 183 | 260 | $51,976 | $7,984 | 15.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 231 | 262 | $29,344 | $5,241 | 17.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 13 | 17 | $23,555 | $4,656 | 19.8% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 17 | 23 | $23,023 | $4,033 | 17.5% |
| 66710 | Destruction of lens tissue using laser | Facility | 2023 | 12 | 13 | $23,387 | $4,020 | 17.2% |
| 66030 | Injection of medication into eye | Office | 2023 | 19 | 28 | $38,864 | $3,767 | 9.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 109 | 109 | $7,085 | $1,353 | 19.1% |
| 92250 | Photography of the retina | Office | 2023 | 40 | 40 | $7,280 | $1,062 | 14.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 70 | 70 | $3,430 | $580.04 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 402 | 696 | $210,888 | $43,769 | 20.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 85 | 140 | $309,960 | $42,175 | 13.6% |
| 65820 | Incision to improve eye fluid flow | Facility | 2022 | 35 | 56 | $178,136 | $37,022 | 20.8% |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2022 | 13 | 200 | $160,600 | $32,475 | 20.2% |
About Dr. Constance Okeke, MD
Dr. Constance Okeke, MD is a Ophthalmology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851328132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constance Okeke, MD has received a total of $717,102 in payments from pharmaceutical and medical device companies, with $145,011 received in 2024. These payments were reported across 666 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($298,503).
As a Medicare-enrolled provider, Okeke has provided services to 10,781 Medicare beneficiaries, totaling 14,001 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Norfolk, VA
- Active Since 06/26/2006
- Last Updated 10/16/2015
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1851328132
Products in Payments
- VYZULTA (Drug) $210,450
- DURYSTA (Drug) $61,340
- OMNI SURGICAL SYSTEM (Device) $49,558
- Rhopressa (Drug) $43,315
- rhopressa (Drug) $29,193
- rocklatan (Drug) $24,072
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $23,650
- iStent inject Trabecular Micro-Bypass Stent System (Device) $21,029
- CyPass (Device) $17,731
- Trabectome (Device) $15,890
- iDose (Device) $13,766
- Rocklatan (Drug) $13,036
- BEPREVE (Drug) $12,407
- OMNI(R) SURGICAL SYSTEM (US) (Device) $12,086
- Centurion (Device) $11,615
- AcrySof (Device) $6,865
- Kahook Dual Blade (Device) $6,036
- ARGOS (Device) $4,560
- AcrySof IQ PanOptix UV IOL (Device) $4,560
- COMBIGAN (Drug) $4,350
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Norfolk
Dr. Elizabeth Yeu-Lin, Md, MD
Ophthalmology — Payments: $1.8M
Ophthalmology $1.8M
Dr. John Sheppard, M.d, M.D
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
Dr. Stephen Scoper, M.d, M.D
Ophthalmology — Payments: $176,701
Ophthalmology $176,701
Dr. Thomas Joly, Md Phd, MD PHD
Ophthalmology — Payments: $69,023
Ophthalmology $69,023
Dr. Samantha Dewundara, Md, MD
Ophthalmology — Payments: $18,653
Ophthalmology $18,653
Dr. Rohit Adyanthaya, Md, MD
Ophthalmology — Payments: $8,864
Ophthalmology $8,864